1,3-dipropyl-8-cyclopentylxanthine has been researched along with interleukin-8 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eidelman, O; Jacobson, K; Jozwik, C; Leighton, X; Metcalf, EL; Murtie, J; Pollard, HB; Srivastava, M; Weinstein, DL; Zhang, J | 1 |
| Anthes, JC; Correll, CC; Phelps, PT | 1 |
2 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and interleukin-8
| Article | Year |
|---|---|
Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
Topics: Algorithms; Cell Line; Child; Cluster Analysis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Expression Regulation; Genetic Therapy; Humans; Interleukin-8; Lung; Models, Biological; NF-kappa B; Oligonucleotide Array Sequence Analysis; Pseudomonas aeruginosa; Receptors, Tumor Necrosis Factor; Respiratory Mucosa; Time Factors; Xanthines | 2001 |
Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Calcium; Cell Line, Tumor; Cyclic AMP; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Intracellular Fluid; Protein Isoforms; Purines; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Urinary Bladder Neoplasms; Xanthines | 2006 |